In a report released today, Phil Nadeau from TD Cowen maintained a Buy rating on Biogen (BIIB – Research Report), with a price target of ...
‘The hangover can last longer than the party’: Biotech is in a major slump, with no end in sight
There are few signs the industry responsible for more than 115,000 Massachusetts jobs is pulling out of its four-year downswing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results